Betting On Cancer Treatment? Keep An Eye On This Company By: Benzinga via Benzinga May 26, 2015 at 15:02 PM EDT NeoStem Inc (NASDAQ: NBS) recently received a grant of $17.7 million to fund the company's effort in research of cell therapy ... Read More >>